IPO
-
-
-
-
-
-
-
Roth Capital Starts ContraFect Corp. (CFRX) at Buy; Market Missing Potential Impact of Bacteriophage Lysins
122,409 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

